Moderna, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | -$5.80 | -$2.55 | -$3.56 |
| Q2 2024 | 5 | -$5.46 | -$2.40 | -$3.35 |
| Q3 2024 | 5 | -$2.94 | -$1.29 | -$1.80 |
| Q4 2024 | 12 | -$3.93 | -$1.70 | -$2.67 |
| Q1 2025 | 6 | -$3.25 | -$2.79 | -$3.02 |
| Q2 2025 | 5 | -$5.03 | -$2.21 | -$3.09 |
| Q3 2025 | 5 | -$2.18 | -$0.96 | -$1.34 |
| Q4 2025 | 5 | -$2.70 | -$1.19 | -$1.66 |
| Q1 2026 | 2 | -$4.38 | -$1.93 | -$2.69 |
| Q2 2026 | 2 | -$4.69 | -$2.06 | -$2.88 |
| Q3 2026 | 2 | -$1.85 | -$0.82 | -$1.14 |
| Q4 2026 | 2 | -$1.35 | -$0.60 | -$0.83 |
Moderna, Inc. Earnings Date And Information
Moderna, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of $-1.91 by $1.94. The company had revenue of 1.86 B for the quarter and had revenue of 6.85 B for the year. Moderna, Inc. has generated $-12 earnings per share over the last year ($-12.34 diluted earnings per share) and currently has a price-to-earnings ratio of -7.12. Moderna, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Moderna, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$1.91 | $0.03 | 1.94 | $1.25 B | $1.86 B |
| 08/01/2024 | Q2 2024 | -$3.35 | -$3.33 | 0.02 | $128.41 M | $241.00 M |
| 05/02/2024 | Q1 2024 | -$3.56 | -$3.08 | 0.48 | $167.00 M | |
| 02/23/2024 | Q4 2023 | $0.57 | $2.81 B | |||
| 11/03/2023 | Q3 2023 | -$9.53 | $1.38 B | $1.83 B | ||
| 08/03/2023 | Q2 2023 | -$3.84 | -$3.62 | 0.22 | $307.67 M | $344.00 M |
| 05/04/2023 | Q1 2023 | -$1.77 | $0.20 | 1.97 | $1.86 B | |
| 02/24/2023 | Q4 2022 | $3.81 | $5.08 B | |||
| 11/03/2022 | Q3 2022 | $3.29 | $2.53 | -0.76 | $3.53 B | $3.22 B |
| 08/03/2022 | Q2 2022 | $4.55 | $5.24 | 0.69 | $4.10 B | $4.57 B |
| 05/04/2022 | Q1 2022 | $5.21 | $8.58 | 3.37 | $5.94 B | |
| 02/25/2022 | Q4 2021 | $12.03 | $6.95 B | |||
| 11/04/2021 | Q3 2021 | $9.05 | $8.27 | -0.78 | $6.08 B | $4.83 B |
| 08/05/2021 | Q2 2021 | $5.96 | $6.93 | 0.97 | $4.21 B | $4.22 B |
| 05/06/2021 | Q1 2021 | $2.39 | $3.05 | 0.66 | $1.74 B | |
| 02/26/2021 | Q4 2020 | -$0.69 | $229.38 M | |||
| 10/30/2020 | Q3 2020 | -$0.59 | $80.60 M | $12.22 M | ||
| 08/06/2020 | Q2 2020 | -$0.31 | $27.51 M | $28.44 M | ||
| 05/07/2020 | Q1 2020 | -$0.37 | -$0.35 | 0.02 | $4.46 M | |
| 02/27/2020 | Q4 2019 | -$0.37 | $10.55 M |
Moderna, Inc. Earnings: Frequently Asked Questions
-
When is Moderna, Inc.'s earnings date?
Moderna, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did Moderna, Inc. beat their earnings estimates last quarter?
In the previous quarter, Moderna, Inc. (:MRNA) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.91 by $1.94.
-
How can I listen to Moderna, Inc.'s earnings conference call?
The conference call for Moderna, Inc.'s latest earnings report can be listened to online.
-
How can I read Moderna, Inc.'s conference call transcript?
The conference call transcript for Moderna, Inc.'s latest earnings report can be read online.
-
How much revenue does Moderna, Inc. generate each year?
Moderna, Inc. (:MRNA) has a recorded annual revenue of $6.85 B.
-
How much profit does Moderna, Inc. generate each year?
Moderna, Inc. (:MRNA) has a recorded net income of $6.85 B. Moderna, Inc. has generated $-12.34 earnings per share over the last four quarters.
-
What is Moderna, Inc.'s price-to-earnings ratio?
Moderna, Inc. (:MRNA) has a price-to-earnings ratio of -7.12 and price/earnings-to-growth ratio is -0.11.
